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A number of observations in the last few years 
have attracted attention to the possibility of viral 
infection in systemic lupus erythematosus ( SLE). 
One of these is the occurrence of interwoven tubular 
structures, usually in the endothelial cells of the 
kidney but also in the lymphocytes and in fibroblasts 
when SLE skin fibroblasts are cultured. These tubu-
lar structures have resembled viruses (they were 
thought by thei~ discoverers to be myxo- or para-
myxoviruses), but it has been argued ( 1) that 
they are not viruses because of their size and ap-
pearance and because they have been produced in 
tissue cultures from subjects who do not have SLE; 
they occur in many other conditions which are not 
related to SLE. These tubular structures do not 
occur, however, in rheumatoid arthritis (RA). The 
conclusion, at this point, would seem to be that 
they are not viruses. Nevertheless, from their ran-
domness and their odd app,earance, it seems likely 
that we may be seeing the effects of a virus, per-
haps a very common ¥irus, on the endoplasmic 
reticulum of the cell. 
There has been a group of papers in which the 
point has been made (2, 3, 4) that the titers of a 
number of viral antibodies (usually myxo- and para-
myxoviruses) am somewhat elevated in patients 
with SLE. It has been argued that this simply 
represents the overall hyper-y-globulinemia of SLE, 
although we have not noted the relationship with 
y-globulin levels. It should be pointed out that there 
has been no outstanding elevation of any particular 
viral antibody titer. The antibody titer to measles, 
an RNA virus, has been consistently elevated to a 
significant degree. This may mean that antibody to 
this virus cross-reacts well with an unidentified RN A 
virus which is actually involved. 
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Cellular Immunity in SLE. Hahn and co-
workers ( 5) have reviewed the evidence for re-
duced delayed hypersensitivity in SLE. About half 
of investigators have noted decreased skin test reac-
tions in this disease. Patients with SLE also tend 
to develop lymphomas somewhat more commonly 
than expected. Presumably these patients do not 
have adequate immunologic surveillance for rejec-
tion of lymphomas on the basis of diminished cellu-
lar immunity. 
Regarding cellular immunity, it is known that 
thymus-derived lymphocytes undergo blastic trans-
formation and produce lymphokines. When the T 
cell has been stimulated, it can also subserve the 
antigen to stimulate B lymphocytes (bone marrow-
derived) to produce antibody. 
With regard to the possible role of a virus in 
SLE and the fact that depressed cellular immunity 
seems to be present, it is fairly well accepted that 
virus infections, in general, decrease delayed hyper-
sensitivity as measured by skin tests and by the 
response of the circulating T cells of the infected 
patient to mitogens like PHA and concanavalin. 
Also, if one adds a virus like rubella to lymphocyte 
cultures, the capacity of the T cells in that culture 
to undergo a response to mitogenic agents is dimin-
ished. 
As is well known, the New Zealand Black 
(NZB) mouse, particularly its F 1 hybrid, is an 
excellent model for SLE. The NZB F 1 hybrid mouse 
has also been shown to have decreased cellular 
immunity ( 6). It has a decreased capacity to in-
duce graft-versus-host disease in a recipient mouse 
strain. There is also a decreased responsiveness to 
mitogenic agents and a high incidence of lymphomas. 
For unexplained reasons, T cells in man form 
rosettes with sheep red blood cells. These rosettes 
represent a measure of the T cells circulating in the 
blood. Wybran and Fudenberg (7), using this 
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method, found that patients with viral infections 
have reduced numbers of circulating T lymphocytes. 
In our laboratory, Drs. Hurd and Giuliano have 
observed decreased numbers of spontaneous rosette-
forming cells in patients with SLE suggesting de-
creased cellular immunity. This could be a result of 
coating with an immunosuppressive globulin or a 
true deficiency of T cells. 
Autoantibody Formation. It should be pointed 
out that in SLE, we are concerned not as much with 
T cell function as with the results of B cell activity 
since these cells produce autoantibodies such as anti-
DNA, both double- and single-stranded, antinuclear 
antibody, anti-RNA, both double- and single-
stranded, as well as other types of autoantibodies. 
Are such autoantibodies found in virus infections? 
Two conditions stand out-one, infectious mono-
nucleosis, an EB virus infection, and the other, 
cytomegalovirus infection. In these conditions, we 
see antinuclear antibody, rheumatoid factor, mixed 
cryoglobulins, Coombs autoantibodies, and so forth. 
The NZB mice are infected with murine leu-
kemia viruses. This strain, unlike other strains, does 
not develop tolerance to the murine leukemia viruses 
and eventually develops antibodies to these viruses. 
These form immune complexes which circulate in 
the blood and in time the mice develop proteinuria. 
The immune complexes eventually deposit in the 
basement membrane of the kidney. If NZB F 1 
hybrids are injected with nonleukemogenic viruses 
such as LCM, which is an RNA virus, or with 
polyoma, which is a DNA virus, antinuclear anti-
body is enhanced, the glomerulonephritis is aggra-
vated and the mortality rate goes up ( 8). These 
viruses, it appears, exert an adjuvant effect in stimu-
lating autoantibody formation. Nucleic acids are 
known to have adjuvant effects. Weight for weight, 
the RNA of the tubercle bacillus is as effective an 
adjuvant as the tubercle bacillus itself (9). Powell 
and Steinberg (10) have examined the adjuvant 
effects in the NZB-NZW mouse of poly I-poly C, 
a synthetic double-stranded RNA, and have found 
an increase in antibody, not only to double-stranded 
RNA, but also an increase to DNA. Cone and 
Johnson (11) have shown that poly A-poly U in-
creased the antibody response against sheep red 
blood cells. One may speculate from these kinds 
of results that the viral nucleic acids may also have 
an adjuvant effect on both antibody and autoanti-
body formation. 
It appears likely that if a virus were to be the 
cause of SLE, it would be so by affecting T lymphocyte 
function. In our laboratory ( 12), we have demon-
strated that T cells produce a relatively low molecu-
lar weight factor, which has a stimulatory effect on 
antibody formation by B cells. Fialkow, Gilchrist 
and Allison ( 13) have shown that T cell stimulation 
can lead to autoantibody formation. F1 hybrid mice 
injected with parental cells undergo a graft-versus-
host reaction in which the donor T cells proliferate. 
These mice develop antinuclear antibody after each 
injection of T cells, presumably because of the 
elaboration of a helper factor by the proliferating T 
cells. 
There is also evidence that a suppressor popula-
tion of T cells exists which presumably inhibits 
autoantibody formation. The first evidence for sup-
pressor T cells came from our laboratory ( 14) in 
a study of the effect of antilymphocyte globulin on 
the immune response of rabbits. When rats were 
treated with this agent, the antibody response to 
keyhole limpet hemocyanin was increased instead 
of reduced. This result has been interpreted by 
others (15) to indicate that there is a type of T 
cell whose function is to suppress the antibody 
response. Subsequently, Baker and co-workers ( 16) 
showed that there was an increased response to 
pneumococcal polysaccharide in mice upon treat-
ment with antithymocyte serum. 
Recently, Steinberg and co-workers ( 17) 
showed that neonatal thymectomy of NZB mice 
accelerated the formation of anti-DNA antibodies 
and that this change could be reversed by grafting 
these mice with one-week old thymuses, but not 
with ten-week old thymuses. Suppressor T cells 
presumably are lost in the NZB F 1 hybrid at an 
early age. This seems to be the cause of the aggra-
vated form of the disease observed in thymectomized 
animals. 
It is well established that autoantibodies develop 
in the aged ( 18). Phytohemagglutinin responsive-
ness, which is a measure of T cell function, also de-
creases. These changes may reflect a loss of suppres-
sor T cells with age in man. When Teague and Friou 
( 19) administered syngenic thymocytes from young 
mice to older mice who were producing antinuclear 
antibodies, these antibodies disappeared, suggesting 
that suppressor T cell function had been restored. 
The explanation for these phenomena, most clearly 
enunciated by ·Allison ( 20), is that we are dealing 
with a particular type of tolerance in the normal 
state which does not permit autoantibodies to form. 
ZIFF: VIRUSES AND THE CONNECTIVE TISSUE DISEASES 59 
This tolerance resides in the T cell, as originally sug-
gested by Weigle (21). The B cells which produce 
antoantibody are not tolerant and when they are 
stimulated by helper substance from helper T cells 
or freed from the suppressive action of suppressor 
T cells, they become free to synthesize autoantibody 
in the presence of autoantigen. In speculating about 
the role of a virus in autoimmune phenomena, one 
might suppose that an infected individual would have 
T cells sensitized to the causative virus, whatever 
virus that might be. This virus could then stimu-
late these sensitized T cells to produce a helper 
substance. As a result, potentially responsive 
(nontolerant) B cells would gain the capacity to 
produce autoantibodies. Thus, viruses might act as 
adjuvants for autoantibody formation by stimulating 
sensitized T cells to produce helper substances, 
which could then stimulate B cells to produce auto-
antibody in the presence of autoantigen. They could 
also interfere in some unexplained manner with the 
suppressor effect of suppressor T cells by producing 
a broad interference with T cell function since, as 
mentioned, T cell levels are, in fact, low in the virus 
diseases ( 7 ) . 
Another interesting line of evidence which 
should be mentioned comes from the studies of 
Lewis and co-workers (22) who have injected 
filtered suspensions of spleens of dogs with SLE 
to CA F 1 mice. These mice have, as a result, de-
veloped antinuclear antibodies. This finding suggests 
the presence of a filterable agent, probably a virus, 
in the affected donor dogs, having the capacity to 
produce antinuclear antibodies. 
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